Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM2 | Q14416 | 1/20 | 0.37 |
| ▸ | TGFBR1 | P36897 | 13/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | MET | P08581 | 1/20 | 0.34 |
| ▸ | ADORA2A | P29274 | 4/20 | 0.32 |
| ▸ | ADORA2B | P29275 | 4/20 | 0.32 |
| ▸ | ADORA1 | P30542 | 4/20 | 0.32 |
| ▸ | TGFBR2 | P37173 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29248276 | 0.81 | TGFBR1 (0.35) | TGFBR1ADORA2AADORA2BADORA1TGFBR2 | |
| SCHEMBL8074244 | 0.69 | FAAH (0.38) | POLB | |
| SCHEMBL22300408 | 0.67 | CYP1A2 (0.50) | GRM2TGFBR1POLB | |
| SCHEMBL15639505 | 0.67 | TGFBR1 (0.49) | TGFBR1TGFBR2 | |
| SCHEMBL7577702 | 0.67 | CREBBP (0.40) | ADORA2AADORA2BADORA1 | |
| SCHEMBL18786198 | 0.66 | POLB (0.44) | GRM2TGFBR1POLBADORA2A | |
| SCHEMBL21863408 | 0.66 | POLB (0.69) | GRM2POLB | |
| SCHEMBL8072413 | 0.65 | ESR1 (0.31) | — | |
| SCHEMBL26003095 | 0.64 | POLB (0.40) | GRM2TGFBR1POLBTGFBR2 | |
| SCHEMBL29248262 | 0.64 | ADORA2A (0.32) | METADORA2AADORA2BADORA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110809577-A | Modulators of adenosine A2A receptor | 雷沃医疗有限公司 | 2020-02-18 | — | — | CN | claimed |
| CN-110809577-A | Modulators of adenosine A2A receptor | 雷沃医疗有限公司 | 2020-02-18 | — | — | CN | disclosed |